RS
SRPT icon

Rakuten Securities’s Sarepta Therapeutics SRPT Stock Holding History

Rakuten Securities’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$39 – 968
2025
Q3 		$39 Sell
2
-185
-99% -$3.3K ﹤0.01% 894
2025
Q2 		$3.2K Buy
187
+126
+207% +$5.38K ﹤0.01% 548
2025
Q1 		$3.89K Buy
61
+4
+7% +$421 ﹤0.01% 516
2024
Q4 		$6.93K Buy
57
+17
+43% +$2.08K ﹤0.01% 435
2024
Q3 		$5K Buy
40
+23
+135% +$3.18K ﹤0.01% 419
2024
Q2 		$2.69K Buy
17
+13
+325% +$1.67K ﹤0.01% 458
2024
Q1 		$518 Sell
4
-4
-50% -$490 ﹤0.01% 613
2023
Q4 		$771 Buy
+8
New +$767 ﹤0.01% 490

Other funds holding SRPT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return